Schizophrenia: open trials in United States

177 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT05956951
Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation
Trial Treatment · Fabio Ferrarelli
University of Pittsburgh, Pittsburgh
Registry updated 2026-06-04
NCT05823532
Anti-Inflammatory Challenge in Schizophrenia
Trial Treatment · Phase 4 · Emory University
Emory University Hospital, Atlanta · Grady Memorial Hospital, Atlanta
Registry updated 2026-06-03
NCT05656469
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Trial Treatment · Phase 4 · Parnassia Groep
SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences, Syracuse
Registry updated 2026-06-02
NCT07196462
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
Trial Treatment · Vanderbilt University Medical Center
Vanderbilt Psychiatric Hospital, Nashville
Registry updated 2026-06-02
NCT07615075
Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia
Trial Treatment · Phase 4 · University of Maryland, Baltimore
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP), Catonsville
Registry updated 2026-05-29
NCT07483294
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Trial Treatment · Phase 4 · Northwell Health
Zucker Hillside Hospital, Glen Oaks
Registry updated 2026-05-26
NCT06174116
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
Trial Treatment · Phase 4 · University of Massachusetts, Worcester
UMass Chan Medical School, Worcester
Registry updated 2026-05-22
NCT07593456
NST-SPARK Open-Label Phase 1 STTR (IGNITE)
Trial Treatment · North Shore Therapeutics, Inc.
Zucker Hillside Hospital, Glen Oaks · Perelman School of Medicine, Philadelphia
Registry updated 2026-05-18
NCT04580134
CLOZAPINE Response in Biotype-1
Trial Treatment · Phase 4 · University of Texas Southwestern Medical Center
University of Georgia, Athens · Beth Israel Deaconess Medical Center, Boston · University of Chicago, Chicago · UT Southwestern Medical Center, Dallas · Hartford Healthcare, Hartford
Registry updated 2026-05-11
NCT06774430
Digital Strategies to Advance Help-Seeking Aim 1 and 2
Research · Columbia University
Columbia University Irving Medical Center, New York
Registry updated 2026-05-05
NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Trial Treatment · Phase 4 · New York State Psychiatric Institute
Augusta University Research Institute, Inc., Augusta · University of Maryland School of Medicine, Baltimore · University of North Carolina at Chapel Hill, Chapel Hill · University of California, Los Angeles, Los Angeles · NYU Langone Medical Center, New York · Manhattan Psychiatric Center, New York · New York State Psychiatric Institute, New York
Registry updated 2026-05-04
NCT05282277
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Trial Treatment · Phase 4 · University of North Carolina, Chapel Hill
University of North Carolina at Chapel Hill, Chapel Hill
Registry updated 2026-04-29
NCT07460453
Racial Disparities in the Expression of Paranoia
Trial Treatment · Indiana University
Department of Psychological and Brain Sciences, Bloomington
Registry updated 2026-04-29
NCT05778591
Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
Trial Treatment · Phase 2 · University of California, Los Angeles
UCLA Semel Institute, Los Angeles
Registry updated 2026-04-28
NCT01730781
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Research · Yale University
Connecticut Mental Health Center, Clinical Neuroscience Research Unit, New Haven
Registry updated 2026-04-27
NCT01409109
Database Registry for Neural Network Biomarkers in Psychosis
Research · University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center, Dallas
Registry updated 2026-04-23
NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophrenia
Trial Treatment · Phase 2 · Sheppard Pratt Health System
Sheppard Pratt Health System, Batlimore
Registry updated 2026-04-07
NCT03971487
Ocrelizumab for Psychosis by Autoimmunity
Trial Treatment · Phase 1/2 · The Methodist Hospital Research Institute
Houston Methodist Research Institute, Houston
Registry updated 2026-04-01
NCT04267003
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
Trial Treatment · University of California, Davis
Imaging Research Center, Sacramento
Registry updated 2026-03-30
NCT07290738
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
Trial Treatment · The University of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston, Houston
Registry updated 2026-03-24
NCT07488156
Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
Trial Treatment · Louisiana State University Health Sciences Center in New Orleans
University Medical Center, New Orleans
Registry updated 2026-03-23
NCT03217110
Cerebellar Stimulation and Cognitive Control
Trial Treatment · Krystal Parker, PhD
University of Iowa, Iowa City
Registry updated 2026-03-19
NCT03794076
Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Trial Treatment · Phase 1/2 · Vishwajit Nimgaonkar, MD PhD
University of Pittsburgh, Pittsburgh
Registry updated 2026-03-19
NCT07469384
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Trial Treatment · Nathan Kline Institute for Psychiatric Research
Nathan Kline Institute, Orangeburg
Registry updated 2026-03-13
NCT06745479
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
Trial Treatment · Rutgers, The State University of New Jersey
Center for Advanced Human Brain Imaging Research, Piscataway
Registry updated 2026-03-11

All Schizophrenia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error